Page 1 of Clinical Trials for fluticasone propionate salmeterol, 181 Total Matches

Show/Hide Clinical Trials Which are Not Seeking New Volunteers

1
Completed
Fluticasone Propionate-salmeterol Combination Adherence in Patients With Chronic Obstructive Pulmonary Disease (COPD)
Last Updated: March 15, 2012
Condition(s): Pulmonary Disease, Chronic Obstructive
2
Completed
Chronic Obstructive Pulmonary Disease (COPD)-Related Outcomes and Costs for Patients on Combination Fluticasone Propionate-Salmeterol Xinafoate 250/50mcg Versus Anticholinergics in a COPD-Comorbid Depression/Anxiety Population
Last Updated: June 16, 2011
Condition(s): Pulmonary Disease, Chronic Obstructive
3
Completed
Chronic Obstructive Pulmonary Disease (COPD)-Related Healthcare Utilization and Costs After Discharge From a Hospitalization or Emergency Department Visit on a Regimen of Fluticasone Propionate-Salmeterol Combination Versus Other Maintenance Therapies
Last Updated: August 4, 2011
Condition(s): Pulmonary Disease, Chronic Obstructive
4
Completed
Risk of Re-Hospitalization in Patients With Chronic Obstructive Pulmonary Disease (COPD) Post Exacerbation
Last Updated: June 23, 2011
Condition(s): Pulmonary Disease, Chronic Obstructive
5
Completed
Impact of Initiating Tiotropium Alone Versus Initiating Tiotropium in Combination With Fluticasone Propionate/Salmeterol Xinafoate Combination (FSC) on Chronic Obstructive Pulmonary Disease-related Outcomes in Patients With Pre-existing Exacerbations
Last Updated: September 15, 2011
Condition(s): Pulmonary Disease, Chronic Obstructive
6
Completed
Use of Fluticasone Propionate/Salmeterol Combination Post Emergency Department Visit
Last Updated: October 20, 2011
Condition(s): Asthma
7
Completed
Repeat Dose Study of Fluticasone Propionate/Salmeterol Versus Fluticasone Propionate + Salmeterol In Asthmatics
Last Updated: October 9, 2008
Condition(s): Asthma
8
Completed
A 12-Month Study Comparing Fluticasone Propionate/Salmeterol (ADVAIR) DISKUS Combination Product 250/50mcg Twice Daily To Fluticasone Propionate (FLOVENT) DISKUS 250 Mcg Twice Daily In Symptomatic Patients With Asthma
Last Updated: May 5, 2011
Condition(s): Asthma
9
Completed
A 12-Month Study Comparing Fluticasone Propionate/Salmeterol (ADVAIR) DISKUS Combination Product 250/50mcg BID To Fluticasone Propionate (FLOVENT) DISKUS 250 Mcg BID In Symptomatic Subjects With Asthma
Last Updated: November 10, 2011
Condition(s): Asthma
10
Recruiting
A Single Centre Study in Healthy Volunteers to Optimise the Rotacap Formulation and ROTAHALER Device for Delivery of Fluticasone Propionate/Salmeterol
Last Updated: March 15, 2012
Condition(s): Asthma
11
Completed
Clinical Assessment Of GW815SF HFA MDI In Pediatric Patients With Bronchial Asthma
Last Updated: June 3, 2010
Condition(s): Bronchial Asthma
12
Recruiting
Comparison of Indacaterol 150 μg Once Daily (o.d.) With Salmeterol/Fluticasone Propionate 50 μg/500 μg Twice Daily (b.i.d.)
Last Updated: March 14, 2012
Condition(s): Chronic Obstructive Pulmonary Disease
13
Completed
Clinical Outcomes of Tiotropium Plus Fluticasone Propionate/Salmeterol Compared With Tiotropium for Chronic Obstructive Pulmonary Disease (COPD) in Korea
Last Updated: March 29, 2010
Condition(s): Chronic Obstructive Pulmonary Disease
14
Completed
Airway Inflammation In Patients With Chronic Obstructive Pulmonary Disease
Last Updated: December 4, 2008
Condition(s): Chronic Obstructive Pulmonary Disease (COPD)
15
Completed
Fluticasone Propionate/Salmeterol Combination 250/50 DISKUS in the Exercise Endurance Time in Patients With Chronic Obstructive Pulmonary Disease
Last Updated: January 19, 2012
Condition(s): Pulmonary Disease, Chronic Obstructive
16
Completed
Pharmacokinetic and Pharmacodynamic (PK and PD) Study of Fluticasone Propionate and Salmeterol Combination Product Delivered in a Capsule-based Inhaler and in a Multi-dose Dry Powder Inhaler in Moderate Asthma Patients and Moderate to Severe Chronic Obstructive Pulmonary Disease (COPD) Patients.
Last Updated: April 19, 2012
Condition(s): Asthma
17
Completed
A 12-Week Study To Assess The Safety Of Fluticasone Propionate/Salmeterol 100/50 HFA Versus Fluticasone Propionate 100 HFA In Children With Asthma
Last Updated: August 30, 2010
Condition(s): Asthma
18
Completed
HZA113091 Efficacy and Safety of Fluticasone Furoate/Vilanterol (GW642444) in Adults and Adolescents
Last Updated: March 15, 2012
Condition(s): Asthma
19
Completed
A Study to Evaluate the 24 Hour Spirometric Effect (FEV1) of Fluticasone Furoate/Vilanterol Inhalation Powder (100mcg Fluticasone Furoate (FF)/25mcg Vilanterol (VI)) Compared With Salmeterol/Fluticasone Propionate Inhalation Powder (50mcg Salmeterol/500mcg Fluticasone Propionate (FP))
Last Updated: April 26, 2012
Condition(s): Pulmonary Disease, Chronic Obstructive
20
Completed
Advair HFA For Chronic Obstructive Pulmonary Disease(COPD)
Last Updated: July 7, 2011
Condition(s): Pulmonary Disease, Chronic Obstructive; Chronic Obstructive Pulmonary Disease (COPD)

Clinical Trials content is provided directly by the U.S. National Institutes of Health via ClinicalTrials.gov and is not reviewed separately by ClinicalTrialsFeeds.org. Every page of specific clinical trials information contains a unique identifier which can be used to find further details directly from the National Institutes of Health.

The URL of this page is: http://clinicaltrialsfeeds.org/clinical-trials/results/?term=fluticasone+propionate+salmeterol

Page 1 of Clinical Trials for fluticasone propionate salmeterol, 181 Total Matches

Get the Latest Results via Email or RSS

Subscribe via Web Newsreaders

Browse

Clinical Trials Background

About